Compounded preparations are dispensed only on a doctor’s prescription.
Short answer: A 2026 systematic review and meta-analysis of eight randomised trials (543 adults) reported reductions in weight, BMI and fat mass compared with placebo, with no serious adverse events related to the extract (PMID 42066439). The authors call for larger, longer trials to confirm the effect.

Why patients ask about white kidney bean extract
Patients who ask about white kidney bean extract for weight management are asking about a plant-derived product. The question for a prescriber is what the trial record shows, and whether a named patient should have a compounded preparation prescribed at all.
The active and its proposed mechanism
The authors of a 2026 meta-analysis describe white kidney bean extracts as rich in α-amylase inhibitors, which “may delay carbohydrate digestion and reduce energy intake” (PMID 42066439). A 2024 randomised trial describes the same mechanism, stating that the extracts can aid weight management “by reducing calorie intake from complex carbohydrates through alpha-amylase inhibition” (PMID 38830962). These are the authors’ descriptions of the proposed mechanism.
What the evidence shows
Systematic review and meta-analysis
The 2026 meta-analysis searched four databases to January 31, 2026, and pooled eight randomised controlled trials with 543 participants. Its random-effects estimates were a mean difference of -1.62 kg in weight, -0.58 kg/m² in body mass index and -1.17 kg in fat mass (PMID 42066439).
The 12-week placebo-controlled trial
A 12-week, double-blind, placebo-controlled randomised trial in adults with overweight and moderate obesity had 81 participants complete the study. Participants took a proprietary standardised extract at a high or a low dose, or a placebo, three times a day before meals during a calorie-restricted diet (PMID 38830962). The authors report that the extract “significantly reduced body weight, fat mass, BMI, waist, hip” measurements, in a dose-dependent manner (PMID 38830962). That result belongs to one proprietary extract and is not a finding for every white kidney bean product.
| Design and participants | Outcome as reported | PMID |
|---|---|---|
| Systematic review and meta-analysis of eight randomised trials (n = 543) in adults with overweight or obesity | Weight MD -1.62 kg; BMI MD -0.58 kg/m²; fat mass MD -1.17 kg; no significant difference in fasting blood glucose, triglycerides or random insulin | 42066439 |
| Randomised, double-blind, placebo-controlled trial, 12 weeks; 81 participants completed; overweight and moderate obesity | Significant reductions in body weight, fat mass, BMI, waist and hip, in a dose-dependent manner (one proprietary extract) | 38830962 |
Doses used in the trials
| Trial arm | Dose as reported | Schedule and duration | PMID |
|---|---|---|---|
| High dose, proprietary standardised extract | 1000 mg | Three times a day, 30 minutes before meals, for 12 weeks | 38830962 |
| Low dose, same proprietary extract | 700 mg | Three times a day, 30 minutes before meals, for 12 weeks | 38830962 |
Safety
The meta-analysis reports that “No serious adverse events related to WKBE were reported” (PMID 42066439). That is a pooled statement across eight trials. The abstract does not break adverse events down by trial, and the review calls for further long-term trials (PMID 42066439).
Limits of the evidence
The authors state that “further large-scale, high-quality, and long-term trials are warranted to confirm its efficacy” (PMID 42066439). The one randomised trial cited here ran for 12 weeks and tested one proprietary extract at two doses (PMID 38830962). Its results do not establish the effect of other white kidney bean products.
Forms and specification
For this active the form discussed here is a capsule. Lynnity prepares compounded capsules on a doctor’s prescription under Good Compounding Practice (GCP). The trials cited above give doses in milligrams of a proprietary extract and do not set a strength for a compounded capsule (PMID 38830962). The prescriber specifies the strength, quantity and directions for the named patient. Preparation takes place in the compounding laboratory in Kuala Lumpur.
How to get this prescribed
A compounded capsule is prepared only on a doctor’s prescription. Ask your doctor to write the prescription for you as a named patient. It must state the active, white kidney bean extract, the strength, the form (capsule), the quantity and the directions. A registered doctor practising in Malaysia issues it. Your doctor then sends the prescription to Lynnity.
To contact the pharmacy, use the contact page. The reviewing pharmacist is Vitthia Rama Murti, RPh (RPh 15632).
If you are already taking a medicine for weight, see nutrient support for patients on GLP-1 therapy. For how an overseas prescription is converted for compounding, see the guide to converting an overseas prescription.
Reviewed by Vitthia Rama Murti, RPh (RPh 15632).
Frequently asked questions
Does white kidney bean extract help with weight management?
A 2026 systematic review and meta-analysis of eight randomised trials reported reductions in weight, body mass index and fat mass compared with placebo (PMID 42066439). The pooled weight difference was a mean of -1.62 kg. The authors call for further large-scale and long-term trials to confirm efficacy.
How does white kidney bean extract work?
The authors of the 2026 meta-analysis describe white kidney bean extracts as rich in α-amylase inhibitors, which may delay carbohydrate digestion and reduce energy intake (PMID 42066439). A 2024 randomised trial describes the same mechanism (PMID 38830962). These are the authors’ descriptions of the proposed mechanism.
Is white kidney bean extract safe to take?
The 2026 meta-analysis reports no serious adverse events related to the extract across its eight trials (PMID 42066439). The review still calls for further long-term trials. A patient should tell their doctor about every medicine and supplement they take before starting any preparation.
What strength should a prescriber specify?
The prescriber specifies the strength, form, quantity and directions for the named patient. The trials cited in this article gave doses in milligrams of a proprietary extract and do not set a strength for a compounded capsule (PMID 38830962). The strength is a clinical decision for the prescriber.

